ORUKA THERAPEUTICS INC (ORKA) Stock Balance Sheet
USA - NASDAQ:ORKA - US6876041087 - Common Stock
27.25 USD
+0.12 (+0.44%)
27.25 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 65.40M | 61.58M | 37.43M | 42.45M | 53.36M | |||
| Marketable Securities | 263.01M | 314.07M | N/A | N/A | N/A | |||
| Other Current Assets | 3.61M | 1.22M | 161.00K | 254.00K | 1.06M | |||
| Total Current Assets | 332.01M | 376.87M | 37.59M | 42.70M | 54.42M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.25M | 1.04M | 257.00K | 368.00K | 485.00K | |||
| Investments And Advances | 23.05M | 18.07M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 103.00K | 43.00K | 12.00K | 18.00K | 18.00K | |||
| Total Non-Current Assets | 25.41M | 19.15M | 269.00K | 386.00K | 503.00K | |||
| TOTAL ASSETS | 357.42M | 396.02M | 37.86M | 43.09M | 54.92M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 4.24M | 3.56M | 275.00K | 798.00K | 2.38M | |||
| Accounts Payable | 4.78M | 9.48M | 362.00K | 334.00K | 1.12M | |||
| Other Current Liabilities | 3.09M | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 12.11M | 13.04M | 637.00K | 1.13M | 3.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.67M | 755.00K | 204.00K | 280.00K | 383.00K | |||
| Total Non-Current Liabilities | 1.67M | 755.00K | 204.00K | 280.00K | 383.00K | |||
| TOTAL LIABILITIES | 13.78M | 13.80M | 841.00K | 1.41M | 3.88M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -129.30M | -83.72M | -188.74M | -183.40M | -173.48M | |||
| Additional Paid In Capital | 470.00M | 463.02M | 225.75M | 225.06M | 224.50M | |||
| Common Shares | 2.97M | 2.97M | 14.00K | 14.00K | 14.00K | |||
| Other Shareholders' Equity | -27.00K | -41.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 37.45M | 37.44M | 1.21M | 1.20M | 1.20M | |||
| Tangible Book Value per Share | 9.10 | 10.13 | 30.64 | 34.70 | 42.51 | |||
| Total Shareholders' Equity | 343.64M | 382.22M | 37.02M | 41.67M | 51.04M | |||
| TOTAL LIABILITIES AND EQUITY | 357.42M | 396.02M | 37.86M | 43.09M | 54.92M | |||
| Statistics | ||||||||
| Current Ratio | 27.42 | 28.89 | 59.01 | 37.72 | 15.56 | |||
| Return On Assets (ROA) | -27.97% | -21.14% | -14.10% | -23.04% | -35.18% | |||
| Return On Equity (ROE) | -29.09% | -21.90% | -14.42% | -23.82% | -37.85% | |||
All data in USD , ROIC based on taxRate of 0.21